Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function
- PMID: 21049487
- PMCID: PMC3258343
- DOI: 10.1002/hipo.20887
Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function
Abstract
Genetic studies have associated deficient function of the serine/threonine kinase Akt1 with schizophrenia. This disorder is associated with developmental, structural, and functional abnormalities of the hippocampus that could be traced to abnormal Akt1 function. To establish a closer connection between Akt1 and hippocampal function, mice with a selective deletion of Akt1 (Akt1(-/-) mice) were examined for physiological and behavioral outcomes dependent on the hippocampus and associated with schizophrenia. Genetic deletion of Akt1 was associated with both impaired proliferative capacity of adult-born hippocampal progenitors and hippocampal long-term potentiation, indicating deficient functions of this brain region associated with neuroplasticity. Moreover, Akt1(-/-) mice demonstrated impairments in contextual fear conditioning and recall of spatial learning, behaviors known to selectively involve the hippocampus. Akt1(-/-) mice also showed reduced prepulse inhibition of the acoustic startle response, a sensorimotor gating response that is perturbed in schizophrenia. Postmortem tissue samples from patients with schizophrenia showed significant reductions of phosphorylated Akt levels in hilar neurons of the dentate gyrus, the neurogenic zone of the hippocampus. Taken together, these results implicate the Akt1 isoform in regulating hippocampal neuroplasticity and cognition and in contributing to the etiology of schizophrenia.
Copyright © 2010 Wiley Periodicals, Inc.
Figures





Similar articles
-
Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia.Neurosci Biobehav Rev. 2011 Jan;35(3):848-70. doi: 10.1016/j.neubiorev.2010.10.005. Epub 2010 Oct 15. Neurosci Biobehav Rev. 2011. PMID: 20951727 Free PMC article. Review.
-
Akting up in the GABA hypothesis of schizophrenia: Akt1 deficiency modulates GABAergic functions and hippocampus-dependent functions.Sci Rep. 2016 Sep 12;6:33095. doi: 10.1038/srep33095. Sci Rep. 2016. PMID: 27615800 Free PMC article.
-
An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia.Neuropsychopharmacology. 2016 Jul;41(8):2052-61. doi: 10.1038/npp.2016.2. Epub 2016 Jan 7. Neuropsychopharmacology. 2016. PMID: 26741285 Free PMC article.
-
Akt3 deletion in mice impairs spatial cognition and hippocampal CA1 long long-term potentiation through downregulation of mTOR.Acta Physiol (Oxf). 2019 Jan;225(1):e13167. doi: 10.1111/apha.13167. Epub 2018 Aug 13. Acta Physiol (Oxf). 2019. PMID: 30053339
-
Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation.Nature. 2011 Apr 28;472(7344):466-70. doi: 10.1038/nature09817. Epub 2011 Apr 3. Nature. 2011. PMID: 21460835 Free PMC article.
Cited by
-
Peripheral biomarkers of treatment-resistant schizophrenia: Genetic, inflammation and stress perspectives.Front Pharmacol. 2022 Oct 12;13:1005702. doi: 10.3389/fphar.2022.1005702. eCollection 2022. Front Pharmacol. 2022. PMID: 36313375 Free PMC article. Review.
-
Unlocking new avenues for neuropsychiatric disease therapy: the emerging potential of Peroxisome proliferator-activated receptors as promising therapeutic targets.Psychopharmacology (Berl). 2024 Aug;241(8):1491-1516. doi: 10.1007/s00213-024-06617-6. Epub 2024 May 27. Psychopharmacology (Berl). 2024. PMID: 38801530 Review.
-
Cross-disorder comparative analysis of comorbid conditions reveals novel autism candidate genes.BMC Genomics. 2017 Apr 20;18(1):315. doi: 10.1186/s12864-017-3667-9. BMC Genomics. 2017. PMID: 28427329 Free PMC article.
-
Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia.Neurosci Biobehav Rev. 2011 Jan;35(3):848-70. doi: 10.1016/j.neubiorev.2010.10.005. Epub 2010 Oct 15. Neurosci Biobehav Rev. 2011. PMID: 20951727 Free PMC article. Review.
-
NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia.Front Cell Neurosci. 2013 Mar 27;7:31. doi: 10.3389/fncel.2013.00031. eCollection 2013. Front Cell Neurosci. 2013. PMID: 23543703 Free PMC article.
References
-
- Bajestan SN, Sabouri AH, Nakamura M, Takashima H, Keikhaee MR, Behdani F, Fayyazi MR, Sargolzaee MR, Bajestan MN, Sabouri Z, Khayami E, Haghighi S, Hashemi SB, Eiraku N, Tufani H, Najmabadi H, Arimura K, Sano A, Osame M. Association of AKT1 haplotype with the risk of schizophrenia in Iranian population. Am J Med Genet B Neuropsychiatr Genet. 2006;141B:383–386. - PubMed
-
- Balu DT, Hodes GE, Hill TE, Ho N, Rahman Z, Bender CN, Ring RH, Dwyer JM, Rosenzweig-Lipson S, Hughes ZA, Schechter LE, Lucki I. Flow cytometric analysis of BrdU incorporation as a high-throughput method for measuring adult neurogenesis in the mouse. J Pharmacol Toxicol Methods. 2009;59:100–107. - PMC - PubMed
-
- Barch DM. The cognitive neuroscience of schizophrenia. Annu Rev Clin Psychol. 2005;1:321–353. - PubMed
-
- Bast T, Feldon J. Hippocampal modulation of sensorimotor processes. Prog Neurobiol. 2003;70:319–345. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous